US-FDA approves Abbott’s spinal cord neurostimulator to treat multi-site pain
News Source:- >>
Abbott's new neurostimulator device Proclaim Plus spinal cord stimulation (SCS) system offers the next-generation stimulation therapy, giving physicians the ability to treat multi-site and evolving pain in spinal cord area. It is designed to fit within a person’s life easily and comfortably, the Proclaim Plus SCS system is recharge-free and inductively coupled with a battery that can last up to 10 years. It can also be used with Abbott's NeuroSphere Virtual Clinic connected care technology, which allows a person to both communicate with a physician through secure in-app video chat and remotely receive stimulation settings in real time regardless of location. The system is build on company’s proprietary therapy that works by mimicking natural patterns found in brain to?deliver increased relief from unbearable pain.
Get in Touch with IEBS | Email us:- '[email protected]'